{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:20:50Z","timestamp":1791548450347,"version":"4.3.4"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL007081"],"award-info":[{"award-number":["T32 HL007081"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajpc.2026.101471","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T08:17:00Z","timestamp":1770797820000},"page":"101471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Maternal cardiometabolic health and the role of GLP-1 receptor agonists from preconception to postpartum: A review of evidence and opportunities"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6248-9015","authenticated-orcid":false,"given":"Sumana","family":"Vardhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Arnott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Xun-Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Frolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raina","family":"Meka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Raghuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Vijay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gune","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajpc.2026.101471_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.focus.2024.100210","article-title":"Cardiovascular risk profile among reproductive-aged women in the U.S.: the behavioral risk factor surveillance system, 2015\u20132020","volume":"3","author":"Boakye","year":"2024","journal-title":"AJPM Focus"},{"key":"10.1016\/j.ajpc.2026.101471_bib0002","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.5888\/pcd16.190105","article-title":"Hypertension and diabetes in non-pregnant women of reproductive age in the United States","volume":"16","author":"Azeez","year":"2019","journal-title":"Prev Chronic Dis"},{"issue":"18","key":"10.1016\/j.ajpc.2026.101471_bib0003","doi-asserted-by":"crossref","first-page":"E902","DOI":"10.1161\/CIR.0000000000000961","article-title":"Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American heart association","volume":"143","author":"Parikh","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101471_bib0004","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamacardio.2020.4097","article-title":"Association of adverse pregnancy outcomes with risk of atherosclerotic cardiovascular disease in postmenopausal women","volume":"5","author":"S\u00f8ndergaard","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"17","key":"10.1016\/j.ajpc.2026.101471_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020717","article-title":"Trends in prepregnancy obesity and association with adverse pregnancy outcomes in the United States, 2013 to 2018","volume":"10","author":"Wang","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-02113-9","article-title":"Prepregnancy overweight and obesity and the risk of adverse pregnancy outcomes","volume":"15","author":"Abdi","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101471_bib0007","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMra1801040","volume":"387","author":"Creanga","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101471_bib0008","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/GCO.0000000000000874","article-title":"How effective are lifestyle interventions for overweight women trying to conceive?","volume":"35","author":"Hiller","year":"2023","journal-title":"Curr Opin Obs Gynecol"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101471_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12690","article-title":"What is known about the use of weight loss medication in women with overweight\/obesity on fertility and reproductive health outcomes? A scoping review","volume":"14","author":"Maslin","year":"2024","journal-title":"Clin Obes"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajog.2024.08.024","article-title":"Glucagon-like peptide-1 receptor agonist use in pregnancy: a review","volume":"232","author":"Drummond","year":"2025","journal-title":"Am J Obs Gynecol"},{"issue":"21","key":"10.1016\/j.ajpc.2026.101471_bib0011","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.2016.6458","article-title":"Trends in obesity among adults in the United States, 2005 to 2014","volume":"315","author":"Flegal","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101471_bib0012","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10995-008-0340-6","article-title":"Prevalence of overweight and obesity among women of childbearing age","volume":"13","author":"Vahratian","year":"2009","journal-title":"Matern Child Health J"},{"issue":"21","key":"10.1016\/j.ajpc.2026.101471_bib0013","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease","volume":"53","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.ajpc.2026.101471_bib0014","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2025.02.033","article-title":"Prepregnancy adiposity, adverse pregnancy outcomes, and cardiovascular disease risk in midlife","volume":"85","author":"Borrowman","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101471_bib0015","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jacc.2021.01.010","article-title":"Impact of obesity on outcomes of pregnancy in women with heart disease","volume":"77","author":"Pfaller","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101471_bib0016","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101471_bib0017","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.str.0000442009.06663.48","article-title":"Guidelines for the prevention of stroke in women a statement for healthcare professionals from the American Heart association\/American stroke association","volume":"45","author":"Bushnell","year":"2014","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.ajpc.2026.101471_bib0018","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","article-title":"Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications","volume":"139","author":"Grandi","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101471_bib0019","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/CIRCRESAHA.123.322001","article-title":"Pregnancy as an early cardiovascular moment: peripartum cardiovascular health","volume":"132","author":"Khan","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2026.101471_bib0020","article-title":"Influence of maternal body mass index on pregnancy complications and outcomes: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol"},{"issue":"22","key":"10.1016\/j.ajpc.2026.101471_bib0021","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.2013.6295","article-title":"Maternal obesity and risk of preterm delivery","volume":"309","author":"Cnattingius","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101471_bib0022","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1161\/CIR.0000000000001124","article-title":"Optimizing pre-pregnancy cardiovascular health to improve outcomes in pregnant and postpartum individuals and offspring: a scientific statement from the American heart association","volume":"147","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0023","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.ijo.0802156","article-title":"Gestational weight gain and postpartum behaviors associated with weight change from early pregnancy to 1 y postpartum","volume":"27","author":"Olson","year":"2003","journal-title":"Int J Obes"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101471_bib0024","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1161\/CIR.0000000000001212","article-title":"Opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes: a scientific statement from the American heart association","volume":"149","author":"Lewey","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12933-024-02184-4","article-title":"Postpartum weight retention and the early evolution of cardiovascular risk over the first 5 years after pregnancy","volume":"23","author":"Kramer","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101471_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003486","article-title":"Maternal weight change from prepregnancy to 18 months postpartum and subsequent risk of hypertension and cardiovascular disease in Danish women: a cohort study","volume":"18","author":"Kirkegaard","year":"2021","journal-title":"PLOS Med"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101471_bib0027","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/AOG.0b013e3181ed74ea","article-title":"Recurrent preeclampsia: the effect of weight change between pregnancies","volume":"116","author":"Mostello","year":"2010","journal-title":"Obs Gynecol"},{"key":"10.1016\/j.ajpc.2026.101471_bib0028","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-med-042921-123851","article-title":"Maternal mortality in the United States: trends and opportunities for prevention","volume":"74","author":"Wang","year":"2023","journal-title":"Annu Rev Med"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101471_bib0029","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1542\/neo.20-10-e561","article-title":"Maternal mortality in the United States: updates on trends, causes, and solutions","volume":"20","author":"Collier","year":"2019","journal-title":"NeoReviews"},{"issue":"24","key":"10.1016\/j.ajpc.2026.101471_bib0030","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1161\/CIR.0000000000000582","volume":"137","author":"Brown","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101471_bib0031","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000004395","article-title":"American College of Obstetricians and Gynecologists Practice Bulletin No. 230. Obesity in pregnancy: ACOG practice bulletin, number 230","volume":"137","year":"2021","journal-title":"Obs Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.ajpc.2026.101471_bib0032","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ijgo.13334","article-title":"Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO pregnancy and non-communicable diseases committee: a FIGO (international federation of gynecology and obstetrics) guideline","volume":"151","author":"McAuliffe","year":"2020","journal-title":"Int J Gynaecol Obs"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101471_bib0033","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jogc.2019.03.026","article-title":"Guideline no. 391-pregnancy and maternal obesity part 1: pre-conception and prenatal care","volume":"41","author":"Maxwell","year":"2019","journal-title":"J Obs Gynaecol Can"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101471_bib0034","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jogc.2019.03.027","article-title":"Guideline no. 392-pregnancy and maternal obesity part 2: team planning for delivery and postpartum care","volume":"41","author":"Maxwell","year":"2019","journal-title":"J Obs Gynaecol Can"},{"key":"10.1016\/j.ajpc.2026.101471_bib0035","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/1471-0528.15386","article-title":"Care of women with obesity in pregnancy: green-top guideline No. 72","volume":"126","author":"Denison","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ajpc.2026.101471_bib0036","unstructured":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of obesity in pregnancy. C-Obs 49. Melbourne, Australia: RANZCOG; 2017."},{"issue":"5","key":"10.1016\/j.ajpc.2026.101471_bib0037","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13199","article-title":"A meta-review of systematic reviews of lifestyle interventions for reducing gestational weight gain in women with overweight or obesity","volume":"22","author":"Fair","year":"2021","journal-title":"Obes Rev"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003883","article-title":"Effects of preconception lifestyle intervention in infertile women with obesity: the FIT-PLESE randomized controlled trial","volume":"19","author":"Legro","year":"2022","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.07.027","article-title":"Weight loss prior to pregnancy and subsequent gestational weight gain: prepare, a randomized clinical trial","volume":"224","author":"LeBlanc","year":"2021","journal-title":"Am J Obs Gynecol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190662","article-title":"Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: a randomized controlled trial","volume":"13","author":"van Dammen","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0041","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12958-024-01339-y","article-title":"Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review","volume":"23","author":"Duah","year":"2025","journal-title":"Reprod Biol Endocrinol"},{"issue":"19","key":"10.1016\/j.ajpc.2026.101471_bib0042","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2008.641","article-title":"Pregnancy and fertility following bariatric surgery: a systematic review","volume":"300","author":"Maggard","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2021.06.087","article-title":"Perinatal outcomes after bariatric surgery","volume":"226","author":"Getahun","year":"2022","journal-title":"Am J Obs Gynecol"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101471_bib0044","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0773","article-title":"Effects of a lifestyle intervention to prevent deterioration in glycemic status among South Asian women with recent gestational diabetes: a randomized clinical trial","volume":"5","author":"Tandon","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101471_bib0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/oby.22070","article-title":"Weight control program and gestational weight gain in disadvantaged women with overweight or obesity: a randomized clinical trial","volume":"26","author":"Cahill","year":"2018","journal-title":"Obes Silver Spring"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101471_bib0046","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jand.2021.11.015","article-title":"Barriers and facilitators to healthy eating and physical activity postpartum: a qualitative systematic review","volume":"122","author":"Ryan","year":"2022","journal-title":"J Acad Nutr Diet"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101471_bib0047","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/jamacardio.2021.4391","article-title":"Interventions to mitigate risk of cardiovascular disease after adverse pregnancy outcomes: a review","volume":"7","author":"Jowell","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2026.101471_bib0048","series-title":"Glucagon-like peptide-1 receptor agonists","author":"Collins","year":"2025"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101471_bib0049","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"issue":"234","key":"10.1016\/j.ajpc.2026.101471_bib0050","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"10.1016\/j.ajpc.2026.101471_bib0051","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101471_bib0052","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"10157","key":"10.1016\/j.ajpc.2026.101471_bib0053","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"issue":"10193","key":"10.1016\/j.ajpc.2026.101471_bib0054","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet L Engl"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101471_bib0055","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101471_bib0056","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0057","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ajpc.2026.101471_bib0058","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0059","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-089477","article-title":"Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis","volume":"15","author":"Squire","year":"2025","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101471_bib0060","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/s41440-025-02418-2","article-title":"Possible mechanisms of action of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight","volume":"48","author":"Tanaka","year":"2025","journal-title":"Hypertens Res J Jpn Soc Hypertens"},{"key":"10.1016\/j.ajpc.2026.101471_bib0061","first-page":"hpaf205","article-title":"GLP-1 receptor agonists and blood pressure: a State-of-the-art review of mechanisms, evidence, and clinical implications","author":"Moiz","year":"2025","journal-title":"Am J Hypertens"},{"issue":"16","key":"10.1016\/j.ajpc.2026.101471_bib0062","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.jacc.2018.12.092","article-title":"Long-term cardiovascular risks associated with adverse pregnancy outcomes: JACC review topic of the week","volume":"73","author":"Lane-Cordova","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101471_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.02.009","article-title":"Endothelial dysfunction in pregnancy metabolic disorders","volume":"1866","author":"Echeverria","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101471_bib0064","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1210\/jc.2006-2083","article-title":"Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers","volume":"92","author":"Stewart","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101471_bib0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MED.0000000000000835","article-title":"Glucagon-like peptide-1 receptor agonists and safety in the preconception period","volume":"30","author":"Minis","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ajpc.2026.101471_bib0066","unstructured":"U.S. Food and Drug Administration. BYETTA (exenatide) [prescribing information]. Published online April 27, 2025. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/021773s9s11s18s22s25lbl.pdf."},{"key":"10.1016\/j.ajpc.2026.101471_bib0067","unstructured":"U.S. Food and Drug Administration. ADLYXIN (lixisenatide) [prescribing information]. Published online April 27, 2025. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/208471s007lbl.pdf."},{"key":"10.1016\/j.ajpc.2026.101471_bib0068","unstructured":"U.S. Food and Drug Administration. TANZEUM (albiglutide) [prescribing information]. Published online April 27, 2025. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/125431s019lbl.pdf."},{"key":"10.1016\/j.ajpc.2026.101471_bib0069","unstructured":"U.S. Food and Drug Administration. OZEMPIC (semaglutide) [prescribing information]. Published online April 27, 2025. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209637lbl.pdf."},{"key":"10.1016\/j.ajpc.2026.101471_bib0070","unstructured":"U.S. Food and Drug Administration. MOUNJARO (tirzepatide) [prescribing information]. Published online April 27, 2025. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215755s000lbl.pdf."},{"issue":"9","key":"10.1016\/j.ajpc.2026.101471_bib0071","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1210\/clinem\/dgaf288","article-title":"Preexisting diabetes and pregnancy: an endocrine society and european society of endocrinology joint clinical practice guideline","volume":"110","author":"Wyckoff","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101471_bib0072","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083550","article-title":"Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six teratology information services","volume":"14","author":"Dao","year":"2024","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101471_bib0073","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101471_bib0074","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70021","article-title":"Pregnancy outcomes after semaglutide exposure","volume":"136","author":"Kolding","year":"2025","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ajpc.2026.101471_bib0075","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.2147\/DDDT.S506957","article-title":"A comprehensive review on the pharmacokinetics and drug-drug interactions of approved GLP-1 receptor agonists and a dual GLP-1\/GIP receptor agonist","volume":"19","author":"Min","year":"2025","journal-title":"Drug Devel Ther"},{"key":"10.1016\/j.ajpc.2026.101471_bib0076","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.addr.2018.07.009","article-title":"Battle of GLP-1 delivery technologies","volume":"130","author":"Yu","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"3\u20134","key":"10.1016\/j.ajpc.2026.101471_bib0077","first-page":"70","article-title":"Pregnancy outcome and liraglutide levels in serum and umbilical vein blood of a woman with type 2 diabetes. A case report","volume":"27","author":"Ivani\u0161evi\u0107","year":"2018","journal-title":"Gynaecol Perinatol"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101471_bib0078","first-page":"563","article-title":"Ex vivo human placental transfer of the peptides pramlintide and exenatide (synthetic exendin-4)","volume":"22","author":"Hiles","year":"2003","journal-title":"Hum Exp Toxicol"},{"issue":"17","key":"10.1016\/j.ajpc.2026.101471_bib0079","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3390\/nu16172886","article-title":"Subcutaneous semaglutide during breastfeeding: infant safety regarding drug transfer into human milk","volume":"16","author":"Diab","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpc.2026.101471_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0081","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/OGX.0000000000001487","article-title":"Effect of GLP1 agonists on reproduction","volume":"81","author":"Couldwell","year":"2026","journal-title":"Obs Gynecol Surv"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101471_bib0082","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0083","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03401383","article-title":"A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome","volume":"14","author":"Jensterle","year":"2015","journal-title":"Hormones"},{"key":"10.1016\/j.ajpc.2026.101471_bib0084","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.obmed.2017.06.003","article-title":"Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight\/obese PCOS women","volume":"7","author":"Zheng","year":"2017","journal-title":"Obes Med"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101471_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2025.01.019","article-title":"Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes","volume":"233","author":"Imbroane","year":"2025","journal-title":"Am J Obs Gynecol"},{"key":"10.1016\/j.ajpc.2026.101471_bib0086","article-title":"Gestational weight gain and hypertensive disorders of pregnancy with prepregnancy and early pregnancy glucagon-like peptide-1 receptor agonist exposure","author":"Pondugula","year":"2025","journal-title":"Obs Gynecol"},{"key":"10.1016\/j.ajpc.2026.101471_bib0087","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.20951","article-title":"Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation","author":"Maya","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101471_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107548","volume":"34","author":"Elkind-Hirsch","year":"2020","journal-title":"J Diabetes Complicat"},{"issue":"Suppl 1","key":"10.1016\/j.ajpc.2026.101471_bib0089","first-page":"S321","article-title":"American diabetes association professional practice committee. 15. Management of diabetes in pregnancy: standards of care in diabetes\u20142026","volume":"49","year":"2025","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ajpc.2026.101471_bib0090","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1210\/clinem\/dgaf288","article-title":"Preexisting diabetes and pregnancy: an endocrine society and european society of endocrinology joint clinical practice guideline","volume":"110","author":"Wyckoff","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0091","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.japh.2023.10.037","article-title":"The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception","volume":"64","author":"Skelley","year":"2024","journal-title":"J Am Pharm Assoc JAPhA"},{"key":"10.1016\/j.ajpc.2026.101471_bib0092","doi-asserted-by":"crossref","unstructured":"Rossen L.M., Hamilton B.E., Abma J.C., et al. Updated methodology to estimate overall and unintended pregnancy rates in the United States. Published online 2023.","DOI":"10.15620\/cdc:124395"},{"key":"10.1016\/j.ajpc.2026.101471_bib0093","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.20947","article-title":"Increasing postpartum use of GLP-1 receptor agonists","author":"Bliddal","year":"2025","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101471_bib0094","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamacardio.2020.1966","article-title":"Use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and cardiovascular disease: a review","volume":"5","author":"Honigberg","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101471_bib0095","doi-asserted-by":"crossref","first-page":"luad167","DOI":"10.1210\/jcemcr\/luad167","article-title":"Semaglutide-induced hyperemesis gravidarum","volume":"2","author":"Okeke","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"8","key":"10.1016\/j.ajpc.2026.101471_bib0096","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1111\/dom.16437","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists\u2019 use during pregnancy: safety data from regulatory clinical trials","volume":"27","author":"Parker","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"S4","key":"10.1016\/j.ajpc.2026.101471_bib0097","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajpc.2026.101471_bib0098","doi-asserted-by":"crossref","DOI":"10.1002\/oby.24336","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American college of lifestyle medicine, the American society for nutrition, the obesity medicine association, and the obesity society","author":"Mozaffarian","year":"2025","journal-title":"Obes Silver Spring"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101471_bib0099","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.04.031","article-title":"Society for maternal-fetal medicine consult series #50: the role of activity restriction in obstetric management: (replaces consult number 33, august 2014)","volume":"223","author":"Lauder","year":"2020","journal-title":"Am J Obs Gynecol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101471_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2025.101681","article-title":"GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies","volume":"51","author":"Scheen","year":"2025","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ajpc.2026.101471_bib0101","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clnesp.2024.10.155","article-title":"Nutritional requirements in pregnancy and lactation","volume":"64","author":"Talebi","year":"2024","journal-title":"Clin Nutr ESPEN"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101471_bib0102","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.4182","article-title":"Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US","volume":"2","author":"Eberly","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101471_bib0103","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101471_bib0104","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/dci24-0091","article-title":"Compounded GLP-1 and Dual GIP\/GLP-1 receptor agonists: a statement from the American diabetes association","volume":"48","author":"Neumiller","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101471_bib0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjcard.2025.03.013","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonist use during the first trimester in pregnant women with type 2 diabetes","volume":"246","author":"Hanif","year":"2025","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101471_bib0106","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/cen.13454","article-title":"Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome","volume":"87","author":"Liu","year":"2017","journal-title":"Clin Endocrinol"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:20:19Z","timestamp":1789039219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726000656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":106,"alternative-id":["S2666667726000656"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101471","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal cardiometabolic health and the role of GLP-1 receptor agonists from preconception to postpartum: A review of evidence and opportunities","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101471"}}